NO20052710L - Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents

Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Info

Publication number
NO20052710L
NO20052710L NO20052710A NO20052710A NO20052710L NO 20052710 L NO20052710 L NO 20052710L NO 20052710 A NO20052710 A NO 20052710A NO 20052710 A NO20052710 A NO 20052710A NO 20052710 L NO20052710 L NO 20052710L
Authority
NO
Norway
Prior art keywords
group
optionally substituted
hydrogen atom
alkyl
processes
Prior art date
Application number
NO20052710A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Guy Bizot-Espiard
Sylvain Rault
Jean-Charles Lancelot
Pierre Renard
Daniel-Henri Caignard
Marina Kopp
Buno Pfeiffer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20052710L publication Critical patent/NO20052710L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20052710A 2002-11-05 2005-06-06 Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO20052710L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213802A FR2846656B1 (fr) 2002-11-05 2002-11-05 Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2003/003277 WO2004043957A1 (fr) 2002-11-05 2003-11-04 Derives d’imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
NO20052710L true NO20052710L (no) 2005-06-06

Family

ID=32104440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052710A NO20052710L (no) 2002-11-05 2005-06-06 Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (27)

Country Link
US (1) US7098220B2 (zh)
EP (1) EP1558612B1 (zh)
JP (1) JP2006508111A (zh)
KR (1) KR100717488B1 (zh)
CN (1) CN100335480C (zh)
AR (1) AR041882A1 (zh)
AT (1) ATE337317T1 (zh)
AU (1) AU2003292323A1 (zh)
BR (1) BR0315800A (zh)
CA (1) CA2504008A1 (zh)
CY (1) CY1105752T1 (zh)
DE (1) DE60307875T2 (zh)
DK (1) DK1558612T3 (zh)
EA (1) EA008446B1 (zh)
ES (1) ES2271653T3 (zh)
FR (1) FR2846656B1 (zh)
HK (1) HK1081964A1 (zh)
MA (1) MA27411A1 (zh)
MX (1) MXPA05004791A (zh)
MY (1) MY135191A (zh)
NO (1) NO20052710L (zh)
NZ (1) NZ539599A (zh)
PL (1) PL375373A1 (zh)
PT (1) PT1558612E (zh)
UA (1) UA80579C2 (zh)
WO (1) WO2004043957A1 (zh)
ZA (1) ZA200503234B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1754483A1 (en) 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
FR2903695B1 (fr) 2006-07-13 2008-10-24 Merck Sante Soc Par Actions Si Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2008016730A2 (en) * 2006-08-02 2008-02-07 Targeted Molecular Diagnostics, Llc Compositions and methods for reducing cellular fat
US8163505B2 (en) 2007-05-22 2012-04-24 The Penn State Research Foundation Methods using PBK1 for identifying agents that treat metabolic disorders
US8507473B2 (en) 2008-09-11 2013-08-13 Arena Pharmaceuticals, Inc. 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders
EP3924343A1 (en) * 2008-09-26 2021-12-22 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
EP2348857B1 (en) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CA2741672A1 (en) * 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
WO2010103040A1 (en) 2009-03-10 2010-09-16 INSERM (Institut National de la Santé et de la Recherche Médicale) 5'-adenosine monophosphate-activated protein kinase (ampk) activators for treating pulmonary hypertension
JP2013510834A (ja) 2009-11-16 2013-03-28 メリテク [1,5]‐ジアゾシン誘導体
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
WO2012033149A1 (ja) * 2010-09-10 2012-03-15 塩野義製薬株式会社 Ampk活性化作用を有するヘテロ環縮合イミダゾール誘導体
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP2906040B1 (en) * 2012-08-22 2021-02-17 Merck Sharp & Dohme Corp. Novel benzimidazole tetrahydropyran derivatives
ES2885424T3 (es) * 2013-03-15 2021-12-13 Knopp Biosciences Llc Imidazo(4,5-B)piridin-2-il amidas como activadores del canal Kv7
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9481653B2 (en) 2014-09-12 2016-11-01 Knopp Biosciences Llc Benzoimidazol-1,2-yl amides as Kv7 channel activators
WO2023044364A1 (en) 2021-09-15 2023-03-23 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
MXPA03006730A (es) * 1996-12-11 2003-10-24 Aventis Pharma Inc Preparacion de 4-hidroxi-3-nitro-2(1h)-piridona.
WO2000012089A1 (en) * 1998-08-31 2000-03-09 Merck & Co., Inc. Novel angiogenesis inhibitors
US6271241B1 (en) * 1999-04-02 2001-08-07 Neurogen Corporation Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors

Also Published As

Publication number Publication date
US7098220B2 (en) 2006-08-29
UA80579C2 (en) 2007-10-10
JP2006508111A (ja) 2006-03-09
EP1558612B1 (fr) 2006-08-23
DE60307875T2 (de) 2007-04-12
CN100335480C (zh) 2007-09-05
EA200500717A1 (ru) 2005-10-27
FR2846656A1 (fr) 2004-05-07
HK1081964A1 (en) 2006-05-26
KR100717488B1 (ko) 2007-05-14
CN1711261A (zh) 2005-12-21
WO2004043957A1 (fr) 2004-05-27
EA008446B1 (ru) 2007-06-29
DK1558612T3 (da) 2006-12-27
ZA200503234B (en) 2006-06-28
DE60307875D1 (de) 2006-10-05
BR0315800A (pt) 2005-09-20
AU2003292323A1 (en) 2004-06-03
ES2271653T3 (es) 2007-04-16
EP1558612A1 (fr) 2005-08-03
MXPA05004791A (es) 2005-07-22
CA2504008A1 (fr) 2004-05-27
PT1558612E (pt) 2006-12-29
MA27411A1 (fr) 2005-06-01
ATE337317T1 (de) 2006-09-15
CY1105752T1 (el) 2010-12-22
MY135191A (en) 2008-02-29
NZ539599A (en) 2007-06-29
PL375373A1 (en) 2005-11-28
AR041882A1 (es) 2005-06-01
FR2846656B1 (fr) 2004-12-24
US20060069117A1 (en) 2006-03-30
KR20050084663A (ko) 2005-08-26

Similar Documents

Publication Publication Date Title
NO20052710L (no) Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20076006L (no) Acetylenderivater
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
NO20072632L (no) Oksadiazolderivater som DGAT-inhibitorer
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
MX344669B (es) Agente antiplaquetas novedoso.
HUP0401784A2 (hu) Heterobiciklikus szerkezetû virális polimeráz inhibitorok, eljárás az elõállításukra, köztitermékek és ezeket tartalmazó gyógyszerkészítmények
NO20076624L (no) Syklisk aminderivat med substituert alkylgruppe
NO20065012L (no) Tetrahydronaftyridin-derivater og fremgangsmate for fremstilling av disse
NO20081169L (no) Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20073283L (no) Nye pyridotienopyrimidinderivater
NO20062083L (no) Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20055167L (no) Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
HUP0402500A2 (hu) Gyulladáskeltő citokinok kibocsátását gátló heterokondenzált pirazol-3-on vegyületek és az ezeket tartalmazó gyógyszerkészítmények
EA200501526A1 (ru) Производные 4-замещённых хинолинов, способ и промежуточные продукты для их получения и содержащие их фармацевтические композиции
NO20091779L (no) Nye indolforbindelser en prosess for deres fremstilling og farmasoytiske sammensetninger som inneholder dem
NO20083753L (no) Nye pyridinylaminoalkylen- og pyridinyloksyalkylen-syklopropanaminer, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende dem
NO20062100L (no) Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
MY140571A (en) Mercaptoimidazoles as ccr2 receptor antagonists
NO20065323L (no) 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav
CO6331309A2 (es) Derivados 6-heterociclico-imidazo[1,2-alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica
NO20050391L (no) Nye fluorinerte benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20064073L (no) Derivater fra 2H- eller 3H-benzo[e]indazol-1-yl-karbamat, deres fremstilling og terapeutisk anvendelse derav
TW200606155A (en) Mercaptoimidazoles as CCR2 receptor antagonists
NO20050572L (no) Nye benzo[b]kromeno-naftyridin-7-on- og pyrano[2',3':7,8]kino[2,3-b]kinoksalin-7-on-forbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application